3 terminated. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Respiratory Failure: new trials by email Literature Review of Respiratory Failure trials Research Report on Respiratory Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Furosemide as Supportive Therapy for COVID-19 Respiratory Failure Nebulized Furosemide, Nebulized Saline - Covid19, Respiratory Failure | Phase 2 / Phase 3 | Terminated | Dr. John Muscedere | 40 | 2021-04-16 | 2023-12-11 |
| Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial Azithromycin, Hydroxychloroquine, Placebo - COVID-19, Respiratory Failure | Phase 3 | Terminated | Frantisek Duska, MD, PhD | 3 | 2020-05-13 | 2020-11-06 |
| Dexmedetomidine Pharmacokinetics-pharmacodynamics in Mechanically Ventilated Children With Single-organ Respiratory Failure dexmedetomidine, Vital signs, blood sampling - Respiratory Failure | Phase 3 | Terminated | University Hospital, Ghent | 1 | 2009-12-01 | 2011-10-04 |
Respiratory Insufficiency (3) · COVID-19 (2)
Respiration Disorders (3) · Respiratory Tract Diseases (3) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Virus Diseases (2)
Azithromycin (1) · Blood Specimen Collection (1) · Dexmedetomidine (1) · Hydroxychloroquine (1)
Dr. John Muscedere (1) · Frantisek Duska, MD, PhD (1) · University Hospital, Ghent (1)
Belgium (1) · Canada (1) · Czechia (1)
John Muscedere, MD (1) · Pieter De Cock, Pharm.D (1)